title: Cell-surface matrix proteins and sialic acids in cell-crystal adhesion; the effect of crystal binding on the viability of human CAKI-1 renal epithelial cells.
abstract: OBJECTIVE
  To investigate the role of sialic acids and cellular matrix proteins as crystal-binding molecules in human calcium-oxalate nephrolithiasis.
  
  
  METHODS
  The well-defined human renal cancer cell line CAKI-1 was used a standard cell culture system. After enzymatic digestion of various cell surface molecules, the binding of alpha2,6 (Sambucus nigra, SN-) and alpha2,3 (Maackia amurensis, MA)-specific lectins to CAKI-1 cells was analysed. Simultaneously, the effect on adhesion and release of calcium oxalate monohydrate crystals was investigated (eight replicates). The effect of crystal adhesion on cell viability was assessed using Trypan blue exclusion (five replicates).
  
  
  RESULTS
  Neuraminidase decreased MA-lectin binding of CAKI-1 cells by 39% (P < 0.05) but elevated SN-lectin binding by 812% (P < 0.05). Simultaneously, crystal binding to CAKI-1 cells was increased by 28% (P > 0.05). Pretreatment with collagenase type I, trypsin and dispase II reduced crystal-binding by 61-74% (P < 0.05) with no effect on sialic acid-specific lectin-binding. However, only collagenase type I and dispase (ratio 4 : 1) were also able to release crystals from their receptor-binding sites (P < 0.05). An increase in the number of cell surface-bound crystals correlated significantly with a decrease in cell viability (P < 0.05).
  
  
  CONCLUSIONS
  alpha2,3-linked sialic acids protect cells from crystal-binding. Much greater SN-lectin binding associated with only moderately increased crystal binding argues against alpha2,6-linked sialic acids as a main target structure of crystals. In contrast, collagen type I, type IV and/or fibronectin seem to be potent crystal-binding molecules on human renal epithelial cells, with collagen type I involved in a potential second step of crystal-cell interaction.
authors.affiliation: Department of Urology, University of Vienna, Austria.
authors.forename: G
authors.initials: G
authors.lastname: Kramer
authors.forename: G E
authors.initials: GE
authors.lastname: Steiner
authors.forename: M
authors.initials: M
authors.lastname: Prinz-Kashani
authors.forename: B
authors.initials: B
authors.lastname: Bursa
authors.forename: M
authors.initials: M
authors.lastname: Marberger
mesh_terms: D002470:Cell Survival; D003460:Crystallization; D004798:Enzymes / Q000494:pharmacology; D004847:Epithelial Cells / Q000378:metabolism; D006801:Humans; D007669:Kidney Calculi / Q000209:etiology* / Q000473:pathology; D037102:Lectins / Q000378:metabolism*; D008565:Membrane Proteins / Q000378:metabolism*; D011485:Protein Binding; D012794:Sialic Acids / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D004798:Enzymes; D037102:Lectins; D008565:Membrane Proteins; D012794:Sialic Acids